Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Fang-bo Cui"'
Autor:
Fenglei Wu, Junnian Zheng, Xiaodong Jiang, Huiyu Wang, Fang-bo Cui, Wei Li, Bao-Xiang Bian, Jian Zhang, Yi-Dong Hong, Xiao-Min Li, Qin Liu, Rutian Li, Zi-Yan Song
Publikováno v:
Oncotarget
// Feng-Lei Wu 1, 9, * , Jian Zhang 2, * , Wei Li 3, * , Bao-Xiang Bian 1 , Yi-Dong Hong 4 , Zi-Yan Song 1 , Hui-Yu Wang 5 , Fang-Bo Cui 6 , Ru-Tian Li 7 , Qin Liu 7 , Xiao-Dong Jiang 1 , Xiao-Min Li 8 and Jun-Nian Zheng 9 1 Department of Onology, Af
Autor:
Anqing Zhu, Er-Yun Gao, Dafu Huang, Dinghu Zhang, Yao Wang, Sheng Ding, Fang-Bo Cui, Feng-Lin Zhang, Yiming Cao, Xia Sun, Shijie Xu
Publikováno v:
International Journal of Nanomedicine
Shijie Xu,1,* Fangbo Cui,2,3,* Dafu Huang,4,* Dinghu Zhang,5 Anqing Zhu,6 Xia Sun,6 Yiming Cao,7 Sheng Ding,7 Yao Wang,7 Eryun Gao,3 Fenglin Zhang3 1Center for Public Health Research, Medical School, Nanjing University, Nanjing, China; 2Department of
Autor:
Guo-feng Yue, Wenjing Hu, Xiaoping Qian, Baorui Liu, Hui Ding, Fang-bo Cui, Rutian Li, Qin Liu, Lixia Yu, Puyuan Wu
Publikováno v:
Cancer Letters. 346:53-62
Docetaxel (DOC) is widely used as radiosensitizer in various tumors, including gastric cancer (GC), but its therapeutic effect remains to be improved. In this study, using docetaxel-loaded nanoparticles (DOC-NPs) based on gelatinase-stimuli strategy,
Autor:
Jing Wang, Xu Zhen, Mi Yang, Baorui Liu, Huiyu Wang, Feng-lei Wu, Puyuan Wu, Qin Liu, Xiaoping Qian, Guo-feng Yue, Lixia Yu, Xiqun Jiang, Rutian Li, Fang-bo Cui
Publikováno v:
ACS Applied Materials & Interfaces. 5:12638-12645
Non-toxic, safe materials and preparation methods are among the most important factors when designing nanoparticles (NPs) for future clinical application. Here we report a novel and facile method encapsulating anticancer drug paclitaxel (PTX) into si
Autor:
Shuang-Qi Chen, Fang-Bo Cui, Wei Tang, Yan Zhang, Hui Wang, Rong-Bao Shu, Min Li, Feng-Lin Zhang, Er-Yun Gao, Peng Sun, Bang-Qin Jiang
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 16(15)
To study the effectiveness of human recombinant endostatin injection (Endostar®) combined with cisplatin doublets in treating advanced non-small cell lung cancer (NSCLC), and to evaluate outcome by CT perfusion imaging.From April 2011 to September 2
Autor:
Mi Yang, Huiyu Wang, Qin Liu, Puyuan Wu, Feng-lei Wu, Fang-bo Cui, Lixia Yu, Rutian Li, Hui Ding, Guo-feng Yue, Xiaoping Qian, Baorui Liu
Publikováno v:
Cancer letters. 363(1)
Aberrant methylation of the transcription factor AP-2 epsilon (TFAP2E) has been attributed to 5-fluorouridine (5-FU) sensitivity. 5-Aza-2'-deoxycytidine (DAC), an epigenetic drug that inhibits DNA methylation, is able to cause reactive expression of
Autor:
Qin Liu, Guo-feng Yue, Jie Shen, Puyuan Wu, Baorui Liu, Wenjing Hu, Lixia Yu, Xiqun Jiang, Rutian Li, Feng-lei Wu, Xiaoping Qian, Chun-Ping Jiang, Fang-bo Cui
Publikováno v:
International Journal of Nanomedicine
Fang-bo Cui,1,* Qin Liu,1,* Ru-Tian Li,1 Jie Shen,1 Pu-yuan Wu,1 Li-Xia Yu,1 Wen-jing Hu,1 Feng-lei Wu,2 Chun-Ping Jiang,1 Guo-feng Yue,2 Xiao-Ping Qian,1 Xi-Qun Jiang,3 Bao-Rui Liu11The Comprehensive Cancer Center of Drum-Tower Hospital, Medical Sch
Autor:
Fang-bo Cui, Qin Liu, Ru-Tian Li, Jie Shen, Pu-yuan Wu, Li-Xia Yu, Wen-jing Hu, Feng-lei Wu, Chun-Ping Jiang, Guo-feng Yue, Xiao-Ping Qian, Xi-Qun Jiang, Bao-Rui Liu
Publikováno v:
International Journal of Nanomedicine; 2014, Vol. 9, p2345-2325, 14p